L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003430
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
L-778,123
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]